Limited Clinical Benefit of Immune Checkpoint Inhibition in Ovarian Cancer with Opportunities in Selected Subtypes.
Saved in:
| Title: | Limited Clinical Benefit of Immune Checkpoint Inhibition in Ovarian Cancer with Opportunities in Selected Subtypes. |
|---|---|
| Authors: | Ratka, Zuzanna1 (AUTHOR), Gamian, Andrzej2 (AUTHOR), Woźniak, Marta1 (AUTHOR) marta.wozniak@umw.edu.pl |
| Source: | International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 11, p4923. 26p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
